Unity Biotechnology, Inc. (UBX) Financials
Stock symbol UBX is outdated, potentially delisted? Maybe it is available on other exchange?
UBX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2025 | 30.3 million | 30.6 million |
| Dec. 31, 2024 | 37.7 million | 31.2 million |
| Sept. 30, 2024 | 47.1 million | 33.0 million |
| June 30, 2024 | 53.5 million | 33.8 million |
UBX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2025 | -6.4 million | 617000 |
| Dec. 31, 2024 | -5.9 million | 805000 |
| Sept. 30, 2024 | -5.2 million | 797000 |
| June 30, 2024 | -4.6 million | 974000 |
UBX Net Income
No data available :(
UBX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2025 | 16.9 million | - | 18.7 million |
| Dec. 31, 2024 | 23.2 million | 19.7 million | 23.5 million |
| Sept. 30, 2024 | 29.0 million | 20.7 million | 20.7 million |
| June 30, 2024 | 34.0 million | 21.7 million | 25.3 million |
UBX Shares Outstanding
UBX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2025 | - | 2.8 million | 4.1 million | 1.2 million |
| Dec. 31, 2024 | - | 935000 | 3.1 million | -1.2 million |
| Sept. 30, 2024 | - | 2.8 million | 3.8 million | - |
| June 30, 2024 | - | 5.5 million | 4.5 million | 979000 |
UBX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2025 | - | -664000 |
| Dec. 31, 2024 | - | -664000 |
| Sept. 30, 2024 | - | 216000 |
| June 30, 2024 | - | 221000 |
UBX
Price: $0.20
52 week price:
Earnings Per Share: -1.63 USD
P/E Ratio: -0.18
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 71934
Market Capitalization: 5.0 million